Dorn Gerald W, Kitsis Richard N
From the Department of Internal Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO (G.W.D.); and Departments of Medicine (Cardiology) and Cell Biology and Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, NY (R.N.K.).
Circ Res. 2015 Jan 2;116(1):167-82. doi: 10.1161/CIRCRESAHA.116.303554. Epub 2014 Oct 16.
Mitochondrial research is experiencing a renaissance, in part, because of the recognition that these endosymbiotic descendants of primordial protobacteria seem to be pursuing their own biological agendas. Not only is mitochondrial metabolism required to produce most of the biochemical energy that supports their eukaryotic hosts (us) but mitochondria can actively (through apoptosis and programmed necrosis) or passively (through reactive oxygen species toxicity) drive cellular dysfunction or demise. The cellular mitochondrial collective autoregulates its population through biogenic renewal and mitophagic culling; mitochondrial fission and fusion, 2 components of mitochondrial dynamism, are increasingly recognized as playing central roles as orchestrators of these processes. Mitochondrial dynamism is rare in striated muscle cells, so cardiac-specific genetic manipulation of mitochondrial fission and fusion factors has proven useful for revealing noncanonical functions of mitochondrial dynamics proteins. Here, we review newly described functions of mitochondrial fusion/fission proteins in cardiac mitochondrial quality control, cell death, calcium signaling, and cardiac development. A mechanistic conceptual paradigm is proposed in which cell death and selective organelle culling are not distinct processes, but are components of a unified and integrated quality control mechanism that exerts different effects when invoked to different degrees, depending on pathophysiological context. This offers a plausible explanation for seemingly paradoxical expression of mitochondrial dynamics and death factors in cardiomyocytes wherein mitochondrial morphometric remodeling does not normally occur and the ability to recover from cell suicide is severely limited.
线粒体研究正在经历一场复兴,部分原因是人们认识到这些原始原细菌的内共生后代似乎在追求自身的生物学目标。线粒体代谢不仅是产生支持其真核宿主(我们)的大部分生物化学能量所必需的,而且线粒体可以通过凋亡和程序性坏死主动地,或通过活性氧毒性被动地驱动细胞功能障碍或死亡。细胞内的线粒体群体通过生物发生更新和线粒体自噬清除来自动调节其数量;线粒体分裂和融合作为线粒体动态变化的两个组成部分,越来越被认为在这些过程中起着核心的协调作用。线粒体动态变化在横纹肌细胞中很少见,因此对线粒体分裂和融合因子进行心脏特异性基因操作已被证明有助于揭示线粒体动力学蛋白的非经典功能。在这里,我们综述了线粒体融合/分裂蛋白在心脏线粒体质量控制、细胞死亡、钙信号传导和心脏发育方面新发现的功能。我们提出了一个机制性概念范式,即细胞死亡和选择性细胞器清除不是不同的过程,而是一个统一的综合质量控制机制的组成部分,该机制根据病理生理背景被不同程度激活时会产生不同的效果。这为心肌细胞中线粒体动态变化和死亡因子看似矛盾的表达提供了一个合理的解释,在心肌细胞中,线粒体形态重塑通常不会发生,而且从细胞自杀中恢复的能力也受到严重限制。